Guido Franceschini

10.1k citations

193 papers · 8.1k indexed · 1 hit paper · h-index 53

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Surgery top 0.5%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism

Papers in

Endocrinology, Diabetes and Metabolism 96
- Diabetes, Cardiovascular Risks, and Lipoproteins 89
Surgery 125
- Lipoproteins and Cardiovascular Health 94
- Cholesterol and Lipid Metabolism 46

Co-authors: Laura Calabresi Cesare R. Sirtori Monica Gomaraschi Franco Bernini Robert W. Mahley Karl H. Weisgraber G. Gianfranceschi Giulia Chiesa
Journals: Atherosclerosis (28 papers)Journal of Lipid Research (10 papers)Journal of Biological Chemistry (8 papers)Arteriosclerosis Thrombosis and Vascular Biology (8 papers)Metabolism (8 papers)
Partner nations: Italy United States Switzerland

In The Last Decade

Guido Franceschini

190 papers receiving 7.8k citations

Hit Papers

align trajectories log scale

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. 1980 · 373 citations

Peers

Countries citing papers authored by Guido Franceschini

Since Specialization

Citations

This map shows the geographic impact of Guido Franceschini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Franceschini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Franceschini more than expected).

Fields of papers citing papers by Guido Franceschini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Franceschini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Franceschini. The network helps show where Guido Franceschini may publish in the future.

Co-authors

The 25 scholars most cited alongside Guido Franceschini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guido Franceschini Line = papers co-authored together Guido Franceschini links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation Scientific Reports ·Massimiliano Ruscica, Margherita Botta, Nicola Ferri, ALEXANDRE MEDEIROS DE ARAÚJO, Chiara Macchi, Guido Franceschini, Paolo Magni, Laura Calabresi, Monica Gomaraschi	2018	36
2	Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice Vascular Pharmacology ·Stefano Manzini, C. Pinna, Marco Busnelli, Manlius Caesar Torquato dos Santos Rocha, Elena Rigamonti, Giulia Ganzetti, F. Dellera, Angelo Sala, Laura Calabresi, Guido Franceschini, Cinzia Parolini, Giulia Chiesa	2015	23
3	[LCAT deficiency: a nephrological diagnosis]. PubMed ·Giuliano Boscutti, Laura Calabresi, Stefano Pizzolitto, Emanuela Boer, Hilwa Dwi Darma, Khalil el Adi, Mohd. Effan Djodie, R.T. Kivaisi, 健飞刘, Jeffrey Bonnett, Guido Franceschini	2011	6
4	Carotid artery structural alterations in patients with apolipoprotein A-I amyloidosis (Leu75Pro) Journal of Hypertension ·M.L. Muiesan, Massimo Salvetti, Anna Paini, Eugenia Belotti, Claudia Agabiti Rosei, Carlo Aggiusti, C. Monteduro, S. Deza, Laura Calabresi, Guido Franceschini, Laura Obici, Gina Gregorini, Giovanni Cancarini, Enrico Agabiti Rosei	2009	1
5	A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred Atherosclerosis ·Laura Calabresi, Peter M. Nilsson, Enrico Pinotti, Monica Gomaraschi, Elda Favari, Maria Pia Adorni, Franco Bernini, Cesare R. Sirtori, S. Calandra, Guido Franceschini, Patrizia Tarugi	2009	28
6	A Model Structure for the Heterodimer apoA-IMilano–apoA-II Supports Its Peculiar Susceptibility to Proteolysis Biophysical Journal ·Shobha, Luca Mollica, Elisabetta Gianazza, Laura Calabresi, Guido Franceschini, Cesare R. Sirtori, Ivano Eberini	2006	13
7	High-density lipoproteins: a therapeutic target for atherosclerotic cardiovascular disease Expert Opinion on Therapeutic Targets ·Monica Gomaraschi, Laura Calabresi, Guido Franceschini	2006	8
8	Clinical Evaluation of Probucol in Hypercholesterolemia: Individual Lipoprotein Responses and Inhibitory Effect on Carotid Atherosclerosis Progression Journal of Cardiovascular Pharmacology ·Damiano Baldassarre, Guido Franceschini, G. Peruzzotti, 登松本, Cesare R. Sirtori	1997	19
9	Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein Atherosclerosis ·Mikko Syvänne, Andre Josiah Budianto, Delia Mary Palmer Owen, Catherine De Geitere, Matti Jauhiainen, Christian Ehnholm, Silvia Michelagnoli, Guido Franceschini, Juhani Kahri, Marja‐Riitta Taskinen	1996	93
10	The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Franco Bernini, Laura Calabresi, Kenneth Tarez Kelso, Guido Franceschini	1996	14
11	Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late‐onset alzheimer's disease Annals of Neurology ·Giovanni B. Frisoni, Stefano Govoni, Cristina Geroldi, Angelo Bianchetti, Laura Calabresi, Guido Franceschini, Marco Trabucchi	1995	117
12	Human apolipoprotein mutants III : diagnosis and treatment Springer eBooks ·Cesare R. Sirtori, Guido Franceschini, H. Bryan Brewer	1993	2
13	In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia. Journal of Clinical Investigation ·P. Roma, Richard E. Gregg, M S Meng, Rosemary Ronan, L A Zech, Guido Franceschini, Cesare R. Sirtori, H. Bryan Brewer	1993	98
14	Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population Atherosclerosis ·José Pablo Werba, Omid Safa, Gemma Gianfranceschi, Silvia Michelagnoli, Cesare R. Sirtori, Guido Franceschini	1993	52
15	Tolerability of fibric acids. comparative data and biochemical bases Pharmacological Research ·P. Sarwesh, Laura Calabresi, José Pablo Werba, Guido Franceschini	1992	17
16	Management of lipoprotein-x accumulation in severe cholestasis by semi-selective ldl-apheresis The American Journal of Medicine ·Guido Franceschini, G Busnach, Giulia Chiesa, Cesare R. Sirtori	1991	7
17	Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients European Journal of Clinical Investigation ·Guido Franceschini, Giulia Chiesa, Cesare R. Sirtori	1991	39
18	In vitro activity of probucol on cholesteryl ester transport Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Giulia Chiesa, Guido Franceschini, Cesare R. Sirtori	1990	8
19	Characterization of A-I-containing lipoproteins in subjects with A-I Milano variant Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Marian C. Cheung, Alex V. Nichols, Patricia J. Blanche, Elaine L. Gong, Guido Franceschini, Cesare R. Sirtori	1988	30
20	Selective and Semiselective Low-Density Lipoprotein Apheresis in Familial Hypercholesterolemia Blood Purification ·G Busnach, S. Z. Wang, Viola Vaccarino, Guido Franceschini, WEI-QIONG CHEN, Michela Perrino, Bruno Brando, Cesare R. Sirtori, L Minetti	1988	6

About Guido Franceschini

Guido Franceschini is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cancer Research, Cardiology and Cardiovascular Medicine and Biochemistry, having authored 193 papers that have together received 8.1k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (94 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (89 papers), Cholesterol and Lipid Metabolism (46 papers), Cancer, Lipids, and Metabolism (36 papers), Peroxisome Proliferator-Activated Receptors (23 papers), Lipid metabolism and disorders (18 papers), Drug Transport and Resistance Mechanisms (14 papers) and Pharmacology and Obesity Treatment (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.0k citations), Surgery (4.5k citations), Cancer Research (1.5k citations), Clinical Biochemistry (640 citations) and Cardiology and Cardiovascular Medicine (1.5k citations). Guido Franceschini has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Laura Calabresi, Cesare R. Sirtori, Monica Gomaraschi, Franco Bernini, Robert W. Mahley, Karl H. Weisgraber, G. Gianfranceschi, Giulia Chiesa, Sara Simonelli and Elda Favari. Their work appears in journals such as Atherosclerosis, Journal of Lipid Research, Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact